Cargando…

Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive: An Open-Label, Randomized, Crossover Study of Estradiol Valerate/Dienogest versus Ethinylestradiol/Levonorgestrel

Background: A novel estradiol-based combined oral contraceptive (COC) is currently available in many countries worldwide, including Europe and the US. Based on previous studies, it is expected that this estradiol-based COC will have a reduced hepatic effect compared with COCs containing ethinylestra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klipping, Christine, Duijkers, Ingrid, Parke, Susanne, Mellinger, Uwe, Serrani, Marco, Junge, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2012
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3585947/ https://www.ncbi.nlm.nih.gov/pubmed/21679006 http://dx.doi.org/10.2165/11591200-000000000-00000

Ejemplares similares

Endometrial safety of an oral contraceptive containing estradiol valerate and dienogest
por: Bitzer, Johannes, et al.
Publicado: (2011)

Contraception with estradiol valerate and dienogest: adherence to the method
por: Fruzzetti, Franca, et al.
Publicado: (2019)

Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
por: Nappi, Rossella E, et al.
Publicado: (2014)

Estradiol valerate and dienogest: a new approach to oral contraception
por: Kiley, Jessica W, et al.
Publicado: (2011)

An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest
por: Fruzzetti, Franca, et al.
Publicado: (2012)

Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest
por: Rafie, Sally, et al.
Publicado: (2013)

Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a real-life setting: results of the CONTENT study
por: Briggs, Paula, et al.
Publicado: (2016)

Review of the safety, efficacy and patient acceptability of the combined dienogest/estradiol valerate contraceptive pill
por: Guida, Maurizio, et al.
Publicado: (2010)

Contraceptive efficacy and safety of estradiol valerate/dienogest in a healthy female population: a multicenter, open-label, uncontrolled Phase III study
por: Yu, Qi, et al.
Publicado: (2018)

Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial
por: Haverinen, Annina H., et al.
Publicado: (2022)

No Interacting Influence of Lavender Oil Preparation Silexan on Oral Contraception Using an Ethinyl Estradiol/Levonorgestrel Combination
por: Heger-Mahn, Doris, et al.
Publicado: (2014)

Ethinylestradiol in combined hormonal contraceptive has a broader effect on serum proteome compared with estradiol valerate: a randomized controlled trial
por: Kangasniemi, M H, et al.
Publicado: (2022)

Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest
por: Fraser, Ian S, et al.
Publicado: (2011)

Impact of estradiol-valerate/dienogest on work productivity and activities of daily living in European and Australian women with heavy menstrual bleeding
por: Wasiak, Radoslaw, et al.
Publicado: (2012)

The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
por: Bonnema, Rachel A., et al.
Publicado: (2011)

Investigation of the Hemostatic Effect of a Transdermal Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene Compared with a Monophasic Oral Contraceptive Containing 0.03 mg Ethinyl Estradiol and 0.15 mg Levonorgestrel: An Open-Label, Randomized, Crossover Study
por: Junge, Wolfgang, et al.
Publicado: (2013)

Contraceptive efficacy and tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: an open-label, multicentre, randomised, controlled study
por: Klipping, Christine, et al.
Publicado: (2012)

Estradiol valerate and alcohol intake: dose-response assessments
por: Quirarte, Gina L, et al.
Publicado: (2007)

Estradiol Valerate Affects Hematological and Hemorheological Parameters in Rats
por: Barath, Barbara, et al.
Publicado: (2022)

551. MK-8591 Does Not Alter the Pharmacokinetics of the Oral Contraceptives Ethinyl Estradiol and Levonorgestrel
por: Ankrom, Wendy, et al.
Publicado: (2018)

Estradiol/levonorgestrel: Pulmonary thromboembolism: case report
Publicado: (2022)

Stereological study of the effects of letrozole and estradiol valerate treatment on the ovary of rats
por: Noorafshan, Ali, et al.
Publicado: (2013)

Endothelial Cells, Ankaferd Hemostat, and Estradiol
por: Ardıçoğlu, Yasemin, et al.
Publicado: (2016)

Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives
por: Benagiano, Giuseppe, et al.
Publicado: (2009)

Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial
por: Hauzman, Erik E, et al.
Publicado: (2013)

Changes of The Uterine Tissue in Rats with Polycystic Ovary Syndrome Induced by Estradiol Valerate
por: Mirabolghasemi, Ghadire, et al.
Publicado: (2017)

The Comparative Pharmaco- and Histokinetics of the Therapeutic Dose of Estradiol Valerate and Bromocriptine in Common Quails
por: Nadeem, Muhammad, et al.
Publicado: (2022)

Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants
por: Ankrom, Wendy, et al.
Publicado: (2020)

Cycle control with an extended-regimen oral contraceptive combining levonorgestrel and ethinyl estradiol that includes continuous low-dose ethinyl estradiol instead of the traditional hormone-free interval
por: Nappi, Rossella E, et al.
Publicado: (2017)

Long-term tolerability of ethinylestradiol 20 µg/drospirenone 3 mg in a flexible extended regimen: results from a randomised, controlled, multicentre study
por: Klipping, Christine, et al.
Publicado: (2012)

The therapeutic effect of bromocriptine as mesylate and estradiol valerate on serum and blood biochemistry of common quails
por: ul- Abideen, Zain, et al.
Publicado: (2021)

A Comparison of the Effects of Transdermal Estradiol and Estradiol Valerate on Endometrial Receptivity in Frozen-thawed Embryo Transfer Cycles: A Randomized Clinical Trial
por: Davar, Robab, et al.
Publicado: (2016)

Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: Yang, Siyuan, et al.
Publicado: (2022)

The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg
por: Krishnan, Sheila, et al.
Publicado: (2010)

Pharmacological sympathetic denervation prevents the development of polycystic ovarian syndrome in rats injected with estradiol valerate
por: Espinoza, Julieta A., et al.
Publicado: (2018)

Effects of early estradiol valerate administration on bone turnover markers in surgically induced menopausal women
por: Vatrasresth, Jarika, et al.
Publicado: (2021)

Clinical behavior of a cohort of adult women with facial acne treated with combined oral contraceptive: ethinylestradiol 20 µg/dienogest 2 mg
por: Palacio-Cardona, John, et al.
Publicado: (2017)

Effect of Efavirenz on Endogenous Progesterone Concentrations and Contraceptive Outcomes among Ugandan HIV Infected Women Coadministering Ethinylestradiol/Levonorgestrel
por: Munkwase, Grant, et al.
Publicado: (2017)

Retracted: Clinical Efficacy of Dienogest versus Levonorgestrel-Releasing Intrauterine System for Adenomyosis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

The Effect of Green Tea Extract on Reproductive Improvement in Estradiol Valerate-Induced Polycystic Ovarian Syndrome in Rat
por: Ghafurniyan, Habibeh, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gi4seeujjgd26tudehc9raluu3